Literature DB >> 32789716

Leveraging Social Media for Cardio-Oncology.

Sherry-Ann Brown1,2, Ryan P Daly3, Narjust Duma4, Eric H Yang5, Naveen Pemmaraju6, Purvi Parwani7, Andrew D Choi8, Juan Lopez-Mattei9,10.   

Abstract

OPINION STATEMENT: As the world becomes more connected through online and offline social networking, there has been much discussion of how the rapid rise of social media could be used in ways that can be productive and instructive in various healthcare specialties, such as Cardiology and its subspecialty areas. In this review, the role of social media in the field of Cardio-Oncology is discussed. With an estimated 17 million cancer survivors in the USA in 2019 and 22 million estimated by 2030, more education and awareness are needed. Networking and collaboration are also needed to meet the needs of our patients and healthcare professionals in this emerging field bridging two disciplines. Cardiovascular disease is second only to recurrence of the primary cancer or diagnosis with a secondary malignancy, as a leading cause of death in cancer survivors. A majority of these survivors are anticipated to be on social media seeking information, support, and ideas for optimizing health. Healthcare professionals in Cardio-Oncology are also online for networking, education, scholarship, career development, and advocacy in this field. Here, we describe the utilization and potential impact of social media in Cardio-Oncology, with inclusion of various hashtags frequently used in the Cardio-Oncology Twitter community.

Entities:  

Keywords:  CardioOnc; CardioOncology; JACCCardioOnc; PrevCardioOnc; SoMe; SoMeCardioOnc; Social Media; Twitter

Mesh:

Year:  2020        PMID: 32789716     DOI: 10.1007/s11864-020-00775-3

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  6 in total

Review 1.  Training and Career Development in Cardio-Oncology Translational and Implementation Science.

Authors:  Sherry-Ann Brown; Eric H Yang; Mary Branch; Craig Beavers; Anne Blaes; Michael G Fradley; Richard K Cheng
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

Review 2.  Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges.

Authors:  Jessica S Little; Rizwan Romee
Journal:  Curr Hematol Malig Rep       Date:  2020-11-11       Impact factor: 3.952

3.  MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells.

Authors:  Guofeng Ma; Wen Xue; Jie Ni; Ran Tao
Journal:  J Oncol       Date:  2022-09-27       Impact factor: 4.501

4.  Leveraging innovation, education, and technology for prevention and health equity: Proceedings from the cardiology oncology innovation ThinkTank 2021.

Authors:  Sherry-Ann Brown; Generika Berman; Jim Logan; Diego Sadler; Rohit Moudgil; Brijesh Patel; Marielle Scherrer-Crosbie; Daniel Addison; Richard K Cheng; Arco J Teske
Journal:  Front Cardiovasc Med       Date:  2022-09-29

Review 5.  Cardio-oncology Training in the COVID-19 Era.

Authors:  Stephanie Feldman; Jennifer Liu; Richard Steingart; Dipti Gupta
Journal:  Curr Treat Options Oncol       Date:  2021-06-07

6.  #JACCCardioOnc: Evolution of a Dedicated Social Media Strategy for JACC: CardioOncology.

Authors:  Sherry-Ann Brown; Eric H Yang; Nosheen Reza; Avirup Guha; Roohi Ismail-Khan; Naveen Pemmaraju; Michael G Fradley; Juan Lopez-Mattei
Journal:  JACC CardioOncol       Date:  2021-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.